Works matching IS 20953941 AND DT 2023 AND VI 20 AND IP 11
Results: 10
TNFSF15 facilitates the differentiation of CD11b+ myeloid cells into vascular pericytes in tumors.
- Published in:
- Cancer Biology & Medicine, 2023, v. 20, n. 11, p. 869, doi. 10.20892/j.issn.2095-3941.2023.0245
- By:
- Publication type:
- Article
Repurposing drugs for solid tumor treatment: focus on immune checkpoint inhibitors.
- Published in:
- Cancer Biology & Medicine, 2023, v. 20, n. 11, p. 856, doi. 10.20892/j.issn.2095-3941.2023.0281
- By:
- Publication type:
- Article
Progress in oncolytic viruses modified with nanomaterials for intravenous application.
- Published in:
- Cancer Biology & Medicine, 2023, v. 20, n. 11, p. 830, doi. 10.20892/j.issn.2095-3941.2023.0275
- By:
- Publication type:
- Article
Targeting the mechano-microenvironment and liver cancer stem cells: a promising therapeutic strategy for liver cancer.
- Published in:
- Cancer Biology & Medicine, 2023, v. 20, n. 11, p. 816, doi. 10.20892/j.issn.2095-3941.2023.0229
- By:
- Publication type:
- Article
The outpost against cancer: universal cancer only markers.
- Published in:
- Cancer Biology & Medicine, 2023, v. 20, n. 11, p. 806, doi. 10.20892/j.issn.2095-3941.2023.0313
- By:
- Publication type:
- Article
Single-arm trials for domestic oncology drug approvals in China.
- Published in:
- Cancer Biology & Medicine, 2023, v. 20, n. 11, p. 799, doi. 10.20892/j.issn.2095-3941.2023.0360
- By:
- Publication type:
- Article
Bacterial therapy: a promising strategy for cancer immunotherapy.
- Published in:
- Cancer Biology & Medicine, 2023, v. 20, n. 11, p. 795, doi. 10.20892/j.issn.2095-3941.2023.0292
- By:
- Publication type:
- Article
Using triple radio-immunotherapy to overcome cancer immunotherapy resistance.
- Published in:
- Cancer Biology & Medicine, 2023, v. 20, n. 11, p. 788, doi. 10.20892/j.issn.2095-3941.2023.0268
- By:
- Publication type:
- Article
Emerging trends in clinical cancer genomic research.
- Published in:
- Cancer Biology & Medicine, 2023, v. 20, n. 11, p. 783, doi. 10.20892/j.issn.2095-3941.2023.0383
- By:
- Publication type:
- Article
Reciprocal activation of antigen-presenting cells and CAR T cells triggers a widespread endogenous anti-tumor immune response through sustained high-level IFNγ production.
- Published in:
- Cancer Biology & Medicine, 2023, v. 20, n. 11, p. 779, doi. 10.20892/j.issn.2095-3941.2023.0324
- By:
- Publication type:
- Article